472 related articles for article (PubMed ID: 18295198)
1. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
Masferrer JL; Zweifel BS; Hardy M; Anderson GD; Dufield D; Cortes-Burgos L; Pufahl RA; Graneto M
J Pharmacol Exp Ther; 2010 Jul; 334(1):294-301. PubMed ID: 20378715
[TBL] [Abstract][Full Text] [Related]
3. CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain.
Cortes-Burgos LA; Zweifel BS; Settle SL; Pufahl RA; Anderson GD; Hardy MM; Weir DE; Hu G; Happa FA; Stewart Z; Muthian S; Graneto MJ; Masferrer JL
Eur J Pharmacol; 2009 Sep; 617(1-3):59-67. PubMed ID: 19580807
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
5. The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages.
Rossi A; Pergola C; Koeberle A; Hoffmann M; Dehm F; Bramanti P; Cuzzocrea S; Werz O; Sautebin L
Br J Pharmacol; 2010 Oct; 161(3):555-70. PubMed ID: 20880396
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells.
Yamashita M; Kushihara M; Hirasawa N; Takasaki W; Takahagi H; Takayanagi M; Ohuchi K
Br J Pharmacol; 2000 Jan; 129(2):367-73. PubMed ID: 10694244
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells.
Li CT; Zhang WP; Lu YB; Fang SH; Yuan YM; Qi LL; Zhang LH; Huang XJ; Zhang L; Chen Z; Wei EQ
J Neurosci Res; 2009 Mar; 87(4):991-1001. PubMed ID: 18951527
[TBL] [Abstract][Full Text] [Related]
8. Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.
Fischer L; Steinhilber D; Werz O
Br J Pharmacol; 2004 Jul; 142(5):861-8. PubMed ID: 15197110
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells.
Zhou GX; Ding XL; Wu SB; Zhang HF; Cao W; Qu LS; Zhang H
Oncol Rep; 2015 Feb; 33(2):661-8. PubMed ID: 25483364
[TBL] [Abstract][Full Text] [Related]
10. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats.
Singh VP; Patil CS; Kulkarni SK
Pharmacol Biochem Behav; 2005 Jul; 81(3):433-9. PubMed ID: 15935457
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 5-lipoxygenase inhibitors, zileuton, A-78773 and ICI-D-2138 in an ionophore (A-23187)-induced pleural inflammation model in the rat.
Rao TS; Currie JL; Shaffer AF; Isakson PC
Life Sci; 1993; 53(9):PL147-52. PubMed ID: 8394967
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 5-lipoxygenase inhibitors in biochemical and functional in vivo assays.
Smith WG; Shaffer AF; Currie JL; Thompson JM; Kim S; Rao T; Isakson PC
J Pharmacol Exp Ther; 1995 Dec; 275(3):1332-8. PubMed ID: 8531100
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of 5-lipoxygenase, zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and paxillin.
Meng Z; Cao R; Yang Z; Liu T; Wang Y; Wang X
Urology; 2013 Dec; 82(6):1452.e7-14. PubMed ID: 24295266
[TBL] [Abstract][Full Text] [Related]
15. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.
Collin M; Rossi A; Cuzzocrea S; Patel NS; Di Paola R; Hadley J; Collino M; Sautebin L; Thiemermann C
J Leukoc Biol; 2004 Nov; 76(5):961-70. PubMed ID: 15328337
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
Chen X; Wang S; Wu N; Sood S; Wang P; Jin Z; Beer DG; Giordano TJ; Lin Y; Shih WC; Lubet RA; Yang CS
Clin Cancer Res; 2004 Oct; 10(19):6703-9. PubMed ID: 15475461
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
Muthuraman S; Sinha S; Vasavi CS; Waidha KM; Basu B; Munussami P; Balamurali MM; Doble M; Saravana Kumar R
Bioorg Med Chem; 2019 Feb; 27(4):604-619. PubMed ID: 30638966
[TBL] [Abstract][Full Text] [Related]
19. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
[TBL] [Abstract][Full Text] [Related]
20. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo.
Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J
Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
